APA Style

JF, M. (). Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week randomized controlled phase 3 trial . : .

MLA Style

JF, Merola. "Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week randomized controlled phase 3 trial". : , . THERAPEUTIC CLASS.